Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

University Hospital Bern

31 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 10 Pharmacology 10 Depression 8 Animal Study 8 Mechanism of Action 6 Addiction 5 Toxicity 5 Clinical Trial 4 Brain Imaging 4 Aging 4 Chronic Pain 3 Emotional Processing 3

Journals

ChemBioChem 3 Open Access CRIS of the University of Bern 2 Neuropharmacology 2 Psychedelics 1 Angewandte Chemie 1 Angewandte Chemie International Edition 1 medRxiv 1 ClinicalTrials.gov 1

Publication history

Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-27 Psilocybin-assistierte Gruppenpsychotherapie bei AbhängigkeitserkrankungenOpen Access CRIS of the University of Bern · 2025-11-30 Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-14 Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsNeuropharmacology · 2025-11-01 Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trialsNeuropharmacology · 2025-10-16 Unterschiedliche Reaktionen und Enzyme in der Psilocybin- Biosynthese bei Inocybe- und Psilocybe -PilzenAngewandte Chemie · 2025-09-20 Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe MushroomsAngewandte Chemie International Edition · 2025-09-20 Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body ExperiencesmedRxiv · 2025-06-24 Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-18 Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesisFEBS Letters · 2024-10-23 The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active SiteChemBioChem · 2024-10-15 Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and miceNeuroscience · 2024-09-02 Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-06-30 Medical Uses and Adverse Effects of PsilocybinThe Primary Care Companion For CNS Disorders · 2024-05-26 Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulatorsFrontiers in Pharmacology · 2024-04-17 Methyl transfer in psilocybin biosynthesisNature Communications · 2024-03-27 Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol AddictionResearch Square · 2024-02-21 Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainMolecular Psychiatry · 2024-02-19 Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depressionNeuroscience Applied · 2022-12-31 Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?Pharmaceuticals · 2022-12-30 Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.ChemBioChem · 2022-11-21 Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International Journal of Molecular Sciences · 2022-11-15 Psilocybin: a revolution in psychedelic medicines in the US?BMJ · 2022-10-05 Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31 Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-04-24 Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16 Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-02 Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30 Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15 Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in miceRevista Brasileira de Farmacognosia · 2010-06-30 The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.Neuropsychopharmacology · 2007-02-13

Author directory